Found 2 hits for monomerid = 200745 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Muscarinic acetylcholine receptor M3
(Homo sapiens (Human)) | BDBM200745
![PNG](/data/jpeg/tenK20/BindingDB_200745.png) (US9233108, 6)Show SMILES CN(CCN(C)C(=O)COc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)[C@H]1CC[C@@H](CC1)OC(C([O-])=O)(c1cccs1)c1cccs1 |wU:36.42,wD:17.17,33.35,(.89,-8.55,;.39,-10.01,;-1.12,-10.3,;-2.13,-9.14,;-3.64,-9.43,;-4.15,-10.88,;-4.65,-8.26,;-4.15,-6.81,;-6.16,-8.55,;-6.67,-10.01,;-8.18,-10.3,;-9.19,-9.14,;-10.7,-9.43,;-11.21,-10.88,;-12.72,-11.17,;-13.22,-12.63,;-14.73,-12.92,;-15.24,-14.38,;-14.23,-15.54,;-16.75,-14.67,;-17.76,-13.5,;-19.27,-13.79,;-19.77,-15.25,;-21.29,-15.54,;-18.77,-16.41,;-19.27,-17.87,;-18.26,-19.03,;-18.77,-20.49,;-16.75,-18.74,;-16.25,-17.29,;-17.25,-16.12,;-10.2,-12.05,;-8.68,-11.76,;1.4,-11.17,;.89,-12.63,;1.9,-13.79,;3.41,-13.5,;3.92,-12.05,;2.91,-10.88,;4.42,-14.67,;5.93,-14.38,;5.64,-12.86,;4.76,-11.6,;6.81,-11.86,;6.22,-15.89,;7.62,-16.54,;7.43,-18.07,;5.92,-18.36,;5.17,-17.01,;7.45,-14.08,;8.1,-12.69,;9.63,-12.88,;9.92,-14.39,;8.57,-15.14,)| Show InChI InChI=1S/C40H46N4O8S2/c1-43(27-9-13-29(14-10-27)52-40(39(49)50,34-5-3-21-53-34)35-6-4-22-54-35)19-20-44(2)37(48)25-51-28-11-7-26(8-12-28)23-41-24-33(46)30-15-17-32(45)38-31(30)16-18-36(47)42-38/h3-8,11-12,15-18,21-22,27,29,33,41,45-46H,9-10,13-14,19-20,23-25H2,1-2H3,(H,42,47)(H,49,50)/p-1/t27-,29-,33-/m0/s1 | Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 1.40 | n/a | n/a | n/a | n/a | n/a | n/a |
ALMIRALL, S.A.
US Patent
| Assay Description The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1... |
US Patent US9233108 (2016)
BindingDB Entry DOI: 10.7270/Q23J3BSN |
More data for this Ligand-Target Pair | |
Beta-2 adrenergic receptor
(Homo sapiens (Human)) | BDBM200745
![PNG](/data/jpeg/tenK20/BindingDB_200745.png) (US9233108, 6)Show SMILES CN(CCN(C)C(=O)COc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)[C@H]1CC[C@@H](CC1)OC(C([O-])=O)(c1cccs1)c1cccs1 |wU:36.42,wD:17.17,33.35,(.89,-8.55,;.39,-10.01,;-1.12,-10.3,;-2.13,-9.14,;-3.64,-9.43,;-4.15,-10.88,;-4.65,-8.26,;-4.15,-6.81,;-6.16,-8.55,;-6.67,-10.01,;-8.18,-10.3,;-9.19,-9.14,;-10.7,-9.43,;-11.21,-10.88,;-12.72,-11.17,;-13.22,-12.63,;-14.73,-12.92,;-15.24,-14.38,;-14.23,-15.54,;-16.75,-14.67,;-17.76,-13.5,;-19.27,-13.79,;-19.77,-15.25,;-21.29,-15.54,;-18.77,-16.41,;-19.27,-17.87,;-18.26,-19.03,;-18.77,-20.49,;-16.75,-18.74,;-16.25,-17.29,;-17.25,-16.12,;-10.2,-12.05,;-8.68,-11.76,;1.4,-11.17,;.89,-12.63,;1.9,-13.79,;3.41,-13.5,;3.92,-12.05,;2.91,-10.88,;4.42,-14.67,;5.93,-14.38,;5.64,-12.86,;4.76,-11.6,;6.81,-11.86,;6.22,-15.89,;7.62,-16.54,;7.43,-18.07,;5.92,-18.36,;5.17,-17.01,;7.45,-14.08,;8.1,-12.69,;9.63,-12.88,;9.92,-14.39,;8.57,-15.14,)| Show InChI InChI=1S/C40H46N4O8S2/c1-43(27-9-13-29(14-10-27)52-40(39(49)50,34-5-3-21-53-34)35-6-4-22-54-35)19-20-44(2)37(48)25-51-28-11-7-26(8-12-28)23-41-24-33(46)30-15-17-32(45)38-31(30)16-18-36(47)42-38/h3-8,11-12,15-18,21-22,27,29,33,41,45-46H,9-10,13-14,19-20,23-25H2,1-2H3,(H,42,47)(H,49,50)/p-1/t27-,29-,33-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | 25 |
ALMIRALL, S.A.
US Patent
| Assay Description The study of binding to human adrenergic beta1 and beta2 receptors was performed using commercial membranes prepared from Sf9 cells where they are ov... |
US Patent US9233108 (2016)
BindingDB Entry DOI: 10.7270/Q23J3BSN |
More data for this Ligand-Target Pair | |